Literature DB >> 7317118

Chromosome breakage and sister chromatid exchange frequencies in scleroderma.

G K Sherer, B B Jackson, E C Leroy.   

Abstract

Peripheral lymphocytes from 3 scleroderma patients with systemic disease and from 3 normal controls were examined for frequencies of chromosomal aberration and sister chromatid exchange (SCE). Significant increases in the levels of chromosomal anomaly and SCE were found for all 3 patients. These results are discussed in terms of the diagnostic potential of SCE in scleroderma and the possible etiologic role of cytogenetic instability in this disease.

Entities:  

Mesh:

Year:  1981        PMID: 7317118     DOI: 10.1002/art.1780241112

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

1.  Sister chromatid exchange frequencies in patients with scleroderma and their relatives.

Authors:  R G Palmer; R S Pereira; C J Dore; A M Denman
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

2.  Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis.

Authors:  F Takeuchi; K Nakano; H Yamada; E Kosuge; M Hirai; H Maeda; Y Moroi
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

3.  Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

Authors:  P G Vlachoyiannopoulos; N Tsifetaki; I Dimitriou; D Galaris; S A Papiris; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

4.  Autoantibodies in childhood scleroderma.

Authors:  R M Bernstein; R S Pereira; A J Holden; C M Black; A Howard; B M Ansell
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

5.  Chromosome studies in systemic sclerosis with consideration of antibodies to topoisomerase I.

Authors:  G J Tsay; J L Lan; S Y Li
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

6.  Familial Raynaud's phenomenon and localized scleroderma associated with essential telangiectasia and cytogenetic abnormalities.

Authors:  C B Bunker; D Atherton; O P Gray; K Tsioupra; J D Delhanty; P M Dowd
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.